Houssein H. Ayoub - Concepedia

Author

Houssein H. Ayoub

Weill Cornell Medical College in Qatar ORCID

Also Known As

AYOUB, Houssein, Ayoub, Houssein H., H Ayoub, H. Ayoub, H. H. Ayoub, HOUSSEIN, Ayoub, Hanouf Ali Ayoub, Hazim Ayoub, Houssein H. Ayoub, Houssein Ayoub

170

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

Weill Cornell Medical College in Qatar Qatar University Cornell University Hamad Medical Corporation Primary Health Care

About

Houssein H. Ayoub is an author at Weill Cornell Medical College in Qatar specializing in medicine, epidemiology, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	40	2.3K
2	Epidemiology	23	37	1.8K
3	Public Health	20	29	1.1K
4	Global Health	6	6	370
5	Critical Care Medicine	1	1	14

Houssein H. Ayoub

Publications

Citations

H-Index

Page 1

	Year	Citations
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections Heba Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, New England Journal of Medicine	2022	562
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar Patrick Tang, Mohammad R. Hasan, Hiam Chemaitelly, Nature Medicine VaccinationVaccine SafetyVaccine DevelopmentCovid-19 PandemicImmunology	2021	460
mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar Hiam Chemaitelly, Hadi M. Yassine, Fatiha M. Benslimane, Nature Medicine VaccinationVaccine SafetyVaccine DevelopmentImmunologyVirology	2021	437
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, New England Journal of Medicine	2022	396
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, Nature Communications	2022	231
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy Laith J. Abu‐Raddad, Hiam Chemaitelly, Peter Coyle, EClinicalMedicine	2021	185
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting Laith J. Abu‐Raddad, Hiam Chemaitelly, Joel A. Malek, Clinical Infectious Diseases	2020	176
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, JAMA	2021	174
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, Scientific Reports	2021	165
Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions Houssein H. Ayoub, Hiam Chemaitelly, Laith J. Abu‐Raddad BMC Medicine	2019	125

Page 1